C4X Discovery Floats on the AIM stock market

31/10/2014 Filed under Accounts, Finance

October has seen the debut float of summ.it client C4X Discovery Holdings plc (C4XD) on the AIM stock market. C4XD is a Manchester based business leading the way in development of new technologies to improve the drug discovery process for novel small molecule therapies. It is using these new technologies to collaborate with pharmaceutical and major biotech companies on novel drug programmes and, separately, to develop its own proprietary pipeline of drug candidates. C4XD’s rational drug design software suite enables users to see the shapes of small molecules in a new level of detail and sophistication. This improved understanding of the three dimensional structures of drugs, and how they bind with target proteins, enables medicinal chemists to pursue rational design of new drugs.
C4XD, previously Conformetrix Limited was formed in 2007, a spin out from Manchester University. The management of C4XD plan to use this latest funding to press forward the progress of two of its current drugs through to clinical trials, towards generating Proof of Concept in man as well as continuing to apply its technology to other high-value areas with high unmet medical need.
Having assisted C4X throughout the process of AIM floatation we all wish them all the very best of luck for the future!
To read more about C4X you can visit their website at www.c4xdiscovery.com